ReviewCurrent cardiology reports2025
Intravascular Coronary Imaging Update: Advances, Clinical Applications, and Future Directions.
Review in Current cardiology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Known Unknowns: Unpacking Controversies and Uncertainties in the 2025 Guidelines for Management of Acute Coronary Syndromes.Current cardiology reports · 2026Review
- Coronary Calcified Nodules: From Pathological Definitions to Intravascular Imaging- and Morphology-Guided PCI.International journal of molecular sciences · 2026Review
- High reproducibility of lipid core burden measurements with near-infrared spectroscopy and intravascular ultrasound imaging catheter.International journal of cardiology. Heart & vasculature · 2026Article
- Intravascular Imaging to Predict the Coronary No-Reflow and Slow-Flow Phenomena: Advances and Perspectives.Reviews in cardiovascular medicine · 2026Review
- Intracoronary Imaging for the Management of Vulnerable Plaques.Journal of clinical medicine · 2026Review
- Spectral computed tomography characterization of coronary atherosclerotic plaque: principles, imaging biomarkers, and clinical significance.Frontiers in cardiovascular medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purpose of the reviewWe sought to review the various intracoronary imaging modalities (intravascular ultrasound, optical coherence tomography, and near-infrared spectroscopy) and the latest evidence supporting their use in clinical practice. RECENT
findingsThere is an increasing body of evidence that demonstrates that imaging-guided strategies are superior to angiography alone to improve outcomes of percutaneous coronary intervention (PCI). An intriguing and promising application is use of these devices to identify and treat high-risk or vulnerable plaques. The application of these modalities in special clinical scenarios is also reviewed. Intravascular imaging provides information beyond the angiogram that can be used to improve patient outcomes during PCI. The emerging evidence has been incorporated into the most recent practice Guideline recommendations. Future research is underway to establish the benefit of intravascular imaging for detection and treatment of vulnerable plaques.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.